These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27460515)

  • 1. Efficacy of levetiracetam in primary hemifacial spasm.
    Kuroda T; Saito Y; Fujita K; Yano S; Ishigaki S; Kato H; Murakami H; Ono K
    J Clin Neurosci; 2016 Dec; 34():213-215. PubMed ID: 27460515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of levetiracetam in hemifacial spasm: a case report.
    Biagio Carrieri P; Petracca M; Montella S
    Clin Neuropharmacol; 2008; 31(3):187-8. PubMed ID: 18520988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Higher efficacy of botulinum toxin therapy for hemifacial spasm recurrence after vascular decompression. Case report and literature review].
    Akulov MA; Shimansky VN; Orlova OR; Zakharov VO; Shevchenko KV; Ogurtsova AA; Orlova AS
    Zh Vopr Neirokhir Im N N Burdenko; 2022; 86(2):89-96. PubMed ID: 35412717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of Hemifacial Spasm with Botulinum Toxin].
    Jost WH; Laskawi R; Palmowski-Wolfe A; Urban PP
    Fortschr Neurol Psychiatr; 2017 Apr; 85(4):194-198. PubMed ID: 28437820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemifacial spasm.
    Abbruzzese G; Berardelli A; Defazio G
    Handb Clin Neurol; 2011; 100():675-80. PubMed ID: 21496615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemifacial spasm: clinical findings and treatment.
    Wang A; Jankovic J
    Muscle Nerve; 1998 Dec; 21(12):1740-7. PubMed ID: 9843077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin as treatment for hemifacial spasm.
    Bandini F; Mazzella L
    Eur Neurol; 1999 Jul; 42(1):49-51. PubMed ID: 10394048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of Hemifacial Spasm with Botulinum Toxin].
    Jost WH; Laskawi R; Palmowski-Wolfe A; Urban PP
    Laryngorhinootologie; 2019 Apr; 98(4):247-251. PubMed ID: 30968378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemifacial spasm and neurovascular compression.
    Lu AY; Yeung JT; Gerrard JL; Michaelides EM; Sekula RF; Bulsara KR
    ScientificWorldJournal; 2014; 2014():349319. PubMed ID: 25405219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
    Kongsengdao S; Kritalukkul S
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
    Frei K; Truong DD; Dressler D
    Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hemifacial spasm of young-onset: Report of two cases.
    Palaram H; Carrera E; Vargas MI; Kleinschmidt A; Fleury V
    J Neurol Sci; 2017 Feb; 373():83-85. PubMed ID: 28131234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam in the treatment of idiopathic hemifacial spasm.
    Deleu D
    Neurology; 2004 Jun; 62(11):2134-5. PubMed ID: 15184638
    [No Abstract]   [Full Text] [Related]  

  • 14. A Study on Clinical Profile of Hemifacial Spasm in India and the Therapeutic Response to Botulinum Toxin Type A Injection as well as Pre and Postinjection Quality of Life.
    Misra AK; Mukherjee J; Kumar S; Guha G; Mohanty B; Ngullie PS; Manna A; Nanda T; Das AK; Tiwari K
    J Assoc Physicians India; 2022 Dec; 70(12):11-12. PubMed ID: 37355970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemifacial spasm: clinical characteristics of 321 Indian patients.
    Batla A; Goyal C; Shukla G; Goyal V; Srivastava A; Behari M
    J Neurol; 2012 Aug; 259(8):1561-5. PubMed ID: 22222858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemifacial spasm through the last three decades: From etiology to efficacy and safety of long-term botulinum toxin treatment.
    Herrero-Infante Y; Rodríguez-Sanz A; Máñez-Miró J; Vivancos-Matellano F
    Clin Neurol Neurosurg; 2021 Apr; 203():106555. PubMed ID: 33662742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment.
    Yuksel B; Genc F; Yaman A; Goksu EO; Ak PD; Gomceli YB
    Acta Neurol Belg; 2019 Mar; 119(1):55-60. PubMed ID: 30178181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemifacial spasm and involuntary facial movements.
    Tan NC; Chan LL; Tan EK
    QJM; 2002 Aug; 95(8):493-500. PubMed ID: 12145388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood-onset hemifacial spasm: successful treatment with botulinum toxin.
    Singer C; Papapetropoulos S; Farronay O
    Pediatr Neurol; 2005 Sep; 33(3):220-2. PubMed ID: 16139741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
    Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
    Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.